Short desc: Qualigenix provides optometry and ophthalmology billing services for eye care practices: exam code selection, vision-versus-medical plan routing, co-managed cataract billing, intravitreal drug and laterality review, LCD-driven documentation checks, and denial follow-up, delivered remotely to practices in 48 states. Every eye care claim depends on a split: vision plan or medical plan, surgeon or co-managing optometrist, right eye or left. Qualigenix checks each split before the claim is sent, from routine exams to cataract surgery and retina injections.
Eye care billing requires deciding, for every visit, whether it goes to the patient's vision plan or medical plan, then coding it with the right exam code family, eye and modifier. Surgery adds a second split: the surgeon and a co-managing optometrist share one global payment, billed with modifiers 54 and 55. In CMS's 2025 data, coding errors made up 31.2% of Medicare ophthalmology improper payments. Qualigenix checks each split before the claim goes out. Book a free billing audit: 786-259-0231.
Eye visits can be billed with the ophthalmology exam codes (92002–92014) or with E/M codes (99202–99215). The right choice depends on the documentation and the payer, and a routine vision exam billed to a medical plan is usually denied.
Anti-VEGF drugs often require prior authorization and step therapy, especially in Medicare Advantage plans. Since July 1, 2020, Medicare has required prior authorization for blepharoplasty and related eyelid procedures performed in hospital outpatient departments.
When a surgeon performs cataract surgery and an optometrist provides post-op care, the surgeon bills with modifier 54 and the optometrist with 55. The transfer-of-care date has to match on both claims, or the split payment is delayed or denied.
Aflibercept, ranibizumab, faricimab and bevacizumab each have their own HCPCS code and billing unit. Units must match the dose, the eye must be marked, and single-dose vials need the JW or JZ wastage modifier.
Many patients carry both a vision plan and a medical plan. Checking only one at check-in leads to claims sent to the wrong plan and balances patients dispute.
Medicare contractors' local coverage determinations (LCDs) limit how often OCT, visual fields and fundus photography are paid, and for which diagnoses. Testing without a covered diagnosis or past the frequency limit is denied.
Missing RT or LT modifiers, eyelid modifiers (E1–E4) or a test billed too soon after the last one are among the most common eye care denials, and among the easiest to prevent.
Medicare covers one pair of eyeglasses or contact lenses after cataract surgery with an intraocular lens, billed under DMEPOS rules. Refraction (92015) isn't covered by Medicare and needs an ABN process to collect from the patient. In CMS's 2025 data, optometry eyewear claims billed to DME contractors ran a 46.4% improper payment rate.
Qualigenix handles each split at the point it's decided, so claims reach the right plan with the right codes.
Our coders choose between eye exam codes and E/M codes based on the documentation and each payer's rules. Qualigenix holds 98.9% coding accuracy across all specialties it codes.
We request and track authorizations for anti-VEGF drugs and eyelid surgery, including step-therapy records, and alert your team before an approval lapses.
For co-managed cataract cases, we coordinate the 54 and 55 claims so the transfer-of-care date and post-op split match between the surgeon and the optometrist.
Every intravitreal drug line is checked for the right code, units that match the dose, the eye treated, and the JW or JZ modifier.
Both vision and medical benefits are verified before the visit, and each visit is routed to the plan that covers it.
Testing claims are checked against the local LCD for a covered diagnosis and frequency limit before they're sent.
Denials are worked by cause and appealed where the record supports payment. Qualigenix overturns 79% of the denials it works.
Post-cataract eyewear is billed under DMEPOS rules, and refraction and other non-covered services are billed with a signed ABN and the right modifier.
Claims go out with an under 24-hour average submission turnaround, payments are posted by vision and medical plan, and unpaid surgery and injection claims are worked first. Reports show revenue by plan type and service line.
A 3-provider podiatry group with roughly 60% Medicare payer mix carried $412,000 in A/R, 38% of it past 120 days. Routine foot care claims (11720, 11721, 11055–11057) had stalled on inconsistent Q7/Q8/Q9 modifiers and class-finding documentation, so payers held or partially paid and nobody worked the remainder. Medicare crossover to secondaries was not being posted, and small patient balances were written off.
We ran a full A/R aging segmentation, worked claims by payer and denial reason rather than by date, rebilled the stalled routine-care claims with corrected modifiers, and reactivated secondary and crossover billing.
A solo podiatrist coding 320 encounters a month was stuck at 82% first-pass acceptance. Routine foot care went out without the systemic-condition diagnosis pairing and class findings Medicare requires, so it read as non-covered. Wound debridement was coded to the wrong depth (11042 for skin and subcutaneous where the note supported 11043 for muscle and fascia). Same-day E/M with a procedure went out without modifier 25 and got bundled.
We rebuilt the coding workflow: diagnosis-to-CPT pairing rules for at-risk foot care, correct Q-modifier logic, depth-based debridement coding tied to the operative note, and disciplined use of modifiers 25 and 59/XS.
A 2-location podiatry practice sat at a 19% denial rate, mostly Medicare routine-foot-care and nail-debridement rejections. The denials clustered in three buckets: medical-necessity rejections on routine foot care (missing qualifying diagnosis and class findings), frequency-edit denials on nail debridement billed inside the 60-day window, and missing Q modifiers that flagged services as non-covered.
We built a front-end denial-prevention layer, checking eligibility and coverage against payer LCDs before claims went out, plus a structured appeal workflow with documentation templates mapped to each denial reason.
Intermediate and comprehensive eye exams for new (92002, 92004) and established (92012, 92014) patients.
Optometry practices General ophthalmology practices Retina specialists Cataract and refractive surgery centers Optometrist and ophthalmologist co-management networks
Eye care practices choose Qualigenix because it codes each eye, each plan and each share of the surgical payment before the claim is sent, where CMS finds eye care coding errors.
Qualigenix prices optometry and ophthalmology billing after reviewing your visit, surgery and injection volume and your payer mix. A free billing audit gives you a quote and shows where claims are leaking. Call 786-259-0231 to start.
Use the 92000-series eye exam codes when the visit meets their exam requirements and the payer accepts them; use E/M codes when the visit is documented by medical decision-making or time. Some payers prefer one family, so we check payer rules before billing.
We check each OCT, visual field and fundus photo claim against the local LCD for a covered diagnosis and the allowed frequency before it's sent. Tests that don't meet the LCD are flagged for an ABN.
Yes. Qualigenix works denied intravitreal and surgery claims first, correcting units, laterality and modifiers and appealing where the record supports payment. Most practices start with a free AR review.
The surgeon bills the surgery with modifier 54 and the optometrist bills post-op care with modifier 55, using the same date of service and matching transfer-of-care dates. Qualigenix coordinates both claims so the split is paid.
Yes. Routine vision care goes to the vision plan and medical eye problems go to the medical plan. Qualigenix verifies both at check-in and routes each visit to the plan that covers it.
Qualigenix works in 133 EMR and EHR platforms and bills from the system your practice already uses. We confirm access and workflow during onboarding.
Qualigenix onboards new practices in 6 days on average. Call 786-259-0231 to set a start date.